Skip to main content
Log in

Analysis of β-catenin mutations and α-, β-, and γ-catenin expression in normal and neoplastic human pituitary tissues

  • Clinical Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

The cadherin-catenin system mediates Ca2+-dependent cell-cell adhesion, and genetic alterations in these molecules play a significant role in multistage carcinogenesis. Mutations in the β-catenin gene, mostly affecting exon 3, have been detected in malignant cell lines and in primary tumors. Immunohistochemical abnormalities in α-, β-, and γ-catenin have been reported in malignant and benign tumors, and nuclear localization of β-catenin has been associated with mutations in exon 3 of this gene.

Mutational analysis of exon 3 of the β-catenin gene was undertaken by polymerase chain reaction (PCR) and sequencing using genomic DNA extracted from frozen tissues, including 4 normal pituitaries, 22 pituitary adenomas, and one pituitary carcinoma. Frozen sections from these cases were used for immunohistochemical detection of β-catenin. We also analyzed immunohistochemical expression of α-, β-, and γ-catenin by paraffin sections from 154 pituitary tumors, including 148 adenomas and 6 carcinomas. Genomic DNA was extracted from paraffin sections of 2 gonadotroph tumors showing nuclear staining for β-catenin and was used for PCR and sequencing of exon 3 of the β-catenin gene.

No mutations in exon 3 of the β-catenin gene were found in any of the 23 cases analyzed by PCR and sequencing. In addition, the 2 cases studied by paraffin section immunohistochemistry, with nuclear staining for β-catenin, were negative for mutations in this exon. Normal pituitary expressed all three catenin proteins. Immunostaining usually showed a membranous pattern of reactivity and was generally stronger in normal pituitary than in the adjacent adenomas. Stains for α-catenin were positive in fewer tumors than for β-catenin. The lowest frequency immunopositive tumors and the weakest immunostaining was for γ-catenin. All medically treated prolactinomas were negative for γ-catenin, whereas treated growth hormone adenomas were less often positive for both α- and γ-catenin than for untreated tumors. The percentage of positive cases for β-catenin was the same in these two groups. Most pituitary carcinomas were negative for both α- and γ-catenin but were β-catenin positive.

These results indicate that (i) mutations in exon 3 of the β-catenin gene are uncommon in pituitary tumors, and (ii) expression of α-, β-, and γ-catenin is decreased in pituitary adenomas compared to normal pituitary tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Potter E, Bergwitz C, Brabant G. The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev 20:207–239, 1999.

    Article  PubMed  CAS  Google Scholar 

  2. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333–339, 1998.

    PubMed  CAS  Google Scholar 

  3. Cerrato A, Fulciniti F, Avallone A, Benincasa G, Palombini L, Grieco M. Beta- and gamma-catenin expression in thyroid carcinomas. J Pathol 185:267–272, 1998.

    Article  PubMed  CAS  Google Scholar 

  4. Huang SH, Wu JC, Chang KJ, Liaw KY, Wang SM. Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue. Thyroid 9:1095–1103, 1999.

    Article  PubMed  CAS  Google Scholar 

  5. Garcia-Rostan G, Tallini G, Herrero A, D’Aquila TG, Carcangiu ML, Rimm DL. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 59:1811–1815, 1999.

    PubMed  CAS  Google Scholar 

  6. Heinrich CA, Lail-Trecker MR, Peluso JJ, White BA. Negative regulation of N-cadherin-mediated cell-cell adhesion by the estrogen receptor signaling pathway in rat pituitary GH3 cells. Endocrine 10:67–76, 1999.

    Article  PubMed  CAS  Google Scholar 

  7. Spangler PR, Delidow BC. Co-regulation of pituitary tumor cell adhesion and prolactin gene expression by glucocorticoid. J Cell Physiol 174:115–124, 1998.

    Article  PubMed  CAS  Google Scholar 

  8. Semba S, Han J-Y, Ikeda H, and Horii A. Frequent nuclear accumulation of beta-catenin in human pituitary adenoma. Cancer Cytopathol 91:42–48, 2001.

    CAS  Google Scholar 

  9. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797–3804, 1997.

    Article  PubMed  CAS  Google Scholar 

  10. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–642, 1996.

    Article  PubMed  CAS  Google Scholar 

  11. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59:3–10, 1996.

    Article  PubMed  CAS  Google Scholar 

  12. Gumbiner BM. Carcinogenesis: a balance between beta-catenin and APC. Curr Biol 7:R443-R446, 1997.

    Article  PubMed  CAS  Google Scholar 

  13. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023–1026, 1996.

    Article  PubMed  CAS  Google Scholar 

  14. Sambrook J, Gisch EF, Maniatis T. A laboratory manual. 2nd ed. Isolation of high-molecular-weight DNA from mammalian cells. Cold Spring Harbor, NY, CSH Laboratory Press, 1989; 9.14–9.19.

    Google Scholar 

  15. Qian X, Jin L, Grande JP, Lloyd RV. Transforming growth factor-beta and p27 expression in pituitary cells. Endocrinology 137:3051–3060, 1996.

    Article  PubMed  CAS  Google Scholar 

  16. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790, 1997.

    Article  PubMed  CAS  Google Scholar 

  17. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 94:10,330–10,334, 1997.

    Article  CAS  Google Scholar 

  18. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, et al. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58:1021–1026, 1998.

    PubMed  CAS  Google Scholar 

  19. Robbins PF, El-Gamil M, Li YF, Kawakami Y, Loftus D, Appella E, Rosenberg SA. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 183:1185–1192, 1996.

    Article  PubMed  CAS  Google Scholar 

  20. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines [see comments]. Science 275:1790–1792, 1997.

    Article  PubMed  CAS  Google Scholar 

  21. Zurawel RH, Chiappa SA, Allen C, Raffel C. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 58:896–899, 1998.

    PubMed  CAS  Google Scholar 

  22. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58:2524–2527, 1998.

    PubMed  CAS  Google Scholar 

  23. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847–8851, 1998.

    Article  Google Scholar 

  24. Palacios J, Gamallo C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 58:1344–1347, 1998.

    PubMed  CAS  Google Scholar 

  25. Voeller HJ, Truica CI, Gelmann EP. Beta-catenin mutations in human prostate cancer. Cancer Res 58:2520–2523, 1998.

    PubMed  CAS  Google Scholar 

  26. Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, et al. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 10:369–376, 1999.

    PubMed  CAS  Google Scholar 

  27. Crundwell MC, Arkell DG, Gearty J, Phillips SM. Genetic alterations in incidentally diagnosed, transitional zone prostate cancer: a seven year follow-up. J Urol 158:1568–1575, 1997.

    Article  PubMed  CAS  Google Scholar 

  28. Ghadimi BM, Behrens J, Hoffmann I, Haensch W, Birchmeier W, Schlag PM. Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer 35:60–65, 1999.

    Article  PubMed  CAS  Google Scholar 

  29. Mialhe A, Louis J, Montlevier S, Peoch M, Pasquier D, Bosson JL, et al. Expression of E-cadherin and alpha-, beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors? Invasion Metastasis 17:124–137, 1997.

    PubMed  CAS  Google Scholar 

  30. Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, et al. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett’s esophagus and esophageal adenocarcinomas. Mod Pathol 11:805–813, 1998.

    PubMed  CAS  Google Scholar 

  31. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Kosma VM. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer 80:477–482, 1999.

    Article  PubMed  CAS  Google Scholar 

  32. Davies BR, Worsley SD, Ponder BA. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology 32:69–80, 1998.

    Article  PubMed  CAS  Google Scholar 

  33. Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, et al. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol 187:523–529, 1999.

    Article  PubMed  CAS  Google Scholar 

  34. Zhang XD, Hersey P. Expression of catenins and p120cas in melanocytic nevi and cutaneous melanoma: deficient alpha-catenin expression is associated with melanoma progression. Pathology 31:239–246, 1999.

    Article  PubMed  CAS  Google Scholar 

  35. Hirvikoski P, Kumpulainen EJ, Virtaniemi JA, Helin HJ, Rantala I, Johansson RT, et al. Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma. Int J Cancer 79:546–550, 1998.

    Article  PubMed  CAS  Google Scholar 

  36. Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, et al. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 19:3817–3826, 1999.

    PubMed  Google Scholar 

  37. Buchner A, Oberneder R, Riesenberg R, Keiditsch E, Hofstetter A. Expression of plakoglobin in renal cell carcinoma. Anticancer Res 18:4231–4235, 1998.

    PubMed  CAS  Google Scholar 

  38. Tada H, Hatoko M, Tanaka A, Kuwahara M, Muramatsu T. Expression of desmoglein I and plakoglobin in skin carcinomas. J Cutan Pathol 27:24–29, 2000.

    Article  PubMed  CAS  Google Scholar 

  39. Valizadeh A, Karayiannakis AJ, el-Hariry I, Kmiot W, Pignatelli M. Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. Am J Pathol 150:1977–1984, 1997.

    PubMed  CAS  Google Scholar 

  40. Jin L, Kulig E, Qian X, Scheitauer BW, Eberhardt NL, Lloyd RV. A human pituitary adenoma cell line proliferates and maintains some differentiated functions following expression of SV40 large T-antigen. Endocr Pathol 9:169–184, 1998.

    CAS  Google Scholar 

  41. Semba S, Kusumi R, Moriya T, Sasano H. Nuclear accumulation of beta catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocr Pathol 11:243–250, 2000.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ricardo V. Lloyd MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tziortzioti, V., Ruebel, K.H., Kuroki, T. et al. Analysis of β-catenin mutations and α-, β-, and γ-catenin expression in normal and neoplastic human pituitary tissues. Endocr Pathol 12, 125–136 (2001). https://doi.org/10.1385/EP:12:2:125

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/EP:12:2:125

Key Words

Navigation